Clinical trials
Obesity trials in Portugal with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 3 |
| 2019 | 3 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 5 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Unknown status | 8 |
| Not yet recruiting | 5 |
| Recruiting | 5 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Universidade do Porto | 6 |
| Faculdade de Motricidade Humana | 3 |
| Harokopio University | 2 |
| Hospital de Sao Sebastiao | 2 |
| Technical University of Lisbon | 2 |
| Unidade Local de Saúde de Coimbra, EPE | 2 |
| Universidade Nova de Lisboa | 2 |
| University of Lisbon | 2 |
| University of Minho | 2 |
| Associação Centro de Apoio Tecnológico Agro Alimentar | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 33 |
| Overweight | 11 |
| Diabetes Mellitus, Type 2 | 4 |
| Weight Loss | 4 |
| Diabetes, Gestational | 2 |
| Genetic Risk Score | 2 |
| Metabolic Diseases | 2 |
| Noncommunicable Diseases | 2 |
| Osteoporosis | 2 |
| Pediatric Obesity | 2 |
Trials
Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.